Naseem Jahangir Ahmed, Riyaz Mirza Shohiab Ur, Joseph Shobhit Priyanshu, Krupa Jesu, Agarwal Mayank, Mathen Pratheesh George, George Oommen K, George Paul V, Jose John, Thomson Viji Samuel
Department of Cardiology, Christian Medical College, Vellore, Tamil Nadu, India.
Ann Pediatr Cardiol. 2023 Nov-Dec;16(6):393-398. doi: 10.4103/apc.apc_163_23. Epub 2024 Apr 23.
In general, the risks associated with transcatheter atrial septal defect (ASD) device closure are reported to be relatively low, but the evidence stems from trials involving adults and older children. Current guidelines do not recommend ASD device closure in children with defect sizes >20 mm due to limited data available in this group of patients. This retrospective study sought to determine the clinical and procedural characteristics of successful transcatheter ASD device closure in small children with large defects and assess the complication rates and reasons for unsuccessful device closure.
We retrospectively reviewed the data of all patients who underwent elective transcatheter closure of ostium secundum ASD in our department between September 2013 and February 2022. All children weighing <20 kg, requiring a device of size 20 mm or greater, were included. Major and minor complications were predefined and indications for referral were evaluated. Echocardiogram reports were reviewed from the time of referral, postcatheterization day 1, and at 1-year follow-up.
We identified 40 patients meeting inclusion criteria with a median (interquartile range [IQR]) procedural age of 5 (4-7) years and median (IQR) weight of 14 (12-18) kg. Successful device closure was achieved in 39 patients with a success rate of 97.5%. The total complication rate was 2.5% (95% confidence interval: 0.44%- I2.8%) with only 1 major complication. All children had right heart enlargement and exertional dyspnea, 30% of patients had recurrent lower respiratory tract infections, and 10% had failure to thrive. At 1-year follow-up, a transthoracic echocardiogram showed a well-endothelialized device in a stable position in all the patients, and none of the patients had a residual shunt.
In experienced centers, percutaneous ASD closure of large defects in symptomatic small children can be done effectively and safely with a great degree of predictability and a low complication rate.
一般而言,经导管房间隔缺损(ASD)封堵术相关风险据报道相对较低,但证据来源于涉及成人和大龄儿童的试验。由于该组患者可用数据有限,当前指南不建议对缺损大小>20mm的儿童进行ASD封堵术。这项回顾性研究旨在确定大型缺损小儿成功经导管ASD封堵术的临床和操作特征,并评估封堵失败的并发症发生率及原因。
我们回顾性分析了2013年9月至2022年2月在我科接受择期继发孔型ASD经导管封堵术的所有患者的数据。纳入所有体重<20kg、需要20mm或更大尺寸封堵器的儿童。预先定义了主要和次要并发症,并评估了转诊指征。回顾了从转诊时、导管插入术后第1天以及1年随访时的超声心动图报告。
我们确定了40例符合纳入标准的患者,手术年龄中位数(四分位间距[IQR])为5(4 - 7)岁,体重中位数(IQR)为14(12 - 18)kg。39例患者成功完成封堵,成功率为97.5%。总并发症发生率为2.5%(95%置信区间:0.44% - 12.8%),仅1例主要并发症。所有儿童均有右心扩大和劳力性呼吸困难,30%的患者有反复下呼吸道感染,10%的患者生长发育迟缓。在1年随访时,经胸超声心动图显示所有患者封堵器内皮化良好且位置稳定,无一例患者有残余分流。
在经验丰富的中心,有症状的小儿大型缺损经皮ASD封堵术可有效、安全地进行,具有高度可预测性且并发症发生率低。